top of page
Employers shouldn’t have to choose between specialty drug access & financial sustainability.
A small share of prescriptions drives the majority of your pharmacy spend. Lower the cost on those, and you transform your entire program.
~5%
of prescriptions are specialty & high-cost brand drugs
~70%
of total pharmacy spend comes from those same scripts
Dramatically reduce employer costs
– with a $0 copay for employee members.
Rescription’s patented technology gives PBMs, Brokers, & Consultants the solution.
FOR EMPLOYERS
Lower high-cost spend tailored to your benefits plan.
FOR BROKERS & CONSULTANTS
A unique solution to secure your book & close new business.
FOR PBMS
Unmatched savings for your clients & their members.
Our patented technology enables multiple solutions to meet you where you are.
1
ADD TO YOUR EXISTING PROGRAM
Integrate Rescription with your current PBM.
Keep your PBM.
2
USE AS YOUR FULL BENEFIT
Make Rescription your complete pharmacy benefit.
Replace your entire PBM.
Both paths unlock the same patented pricing, applied up-front, at the pharmacy counter.
DRUGS | TYPICAL POST-REBATE | RESCRIPTION UP-FRONT | YOUR SAVINGS |
|---|---|---|---|
Xiidra | $438 | $120 | $318 |
Xarelto | $443 | $81 | $362 |
Taltz | $7,540 | $3,699 | $3,841 |
Otezla | $2,117 | $325 | $1,792 |
Norditropin Flexpro | $6,931 | $1,265 | $5,665 |
Menopur | $3,635 | $250 | $3,385 |
Gonal | $2,843 | $369 | $2,474 |
Linzess | $399 | $64 | $335 |
Enbrel | $3,185 | $510 | $2,675 |
Eliquis | $384 | $79 | $305 |
bottom of page
